Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 5/20 | 0.45 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.45 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.45 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.45 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.44 |
| ▸ | ADH1C | P00326 | 1/20 | 0.44 |
| ▸ | ADH1A | P07327 | 1/20 | 0.44 |
| ▸ | ADH4 | P08319 | 1/20 | 0.44 |
| ▸ | ADH7 | P40394 | 1/20 | 0.44 |
| ▸ | ANPEP | P15144 | 1/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.39 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL229789 | 1.00 | S1PR2 (0.45) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL10873346 | 1.00 | S1PR2 (0.45) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL3042142 | 1.00 | S1PR2 (0.45) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL7742223 | 1.00 | S1PR2 (0.45) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL28854764 | 1.00 | S1PR2 (0.45) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL29204913 | 1.00 | S1PR2 (0.45) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL4797826 | 0.98 | ALDH1A1 (0.43) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL2589834 | 0.90 | — | — | |
| SCHEMBL29895708 | 0.90 | S1PR2 (0.47) | S1PR2S1PR4S1PR1S1PR3S1PR5 | |
| SCHEMBL7882684 | 0.88 | PPARA (0.54) | PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0119487-B1 | NOVEL N-ALIPHATIC AND N,N-ALIPHATIC PHOSPHORIC TRIAMIDE UREASE INHIBITORS AND UREASE INHIBITED UREA BASED FERTILIZER COMPOSITIONS | ALLIED CORPORATION (US) | 1986-07-16 | — | — | EP | claimed |
| US-20250276942-A1 | UREASE INHIBITOR FORMULATION FOR USE IN UREA GRANULATION PROCESS | BASF SE (DE) | 2025-09-04 | — | — | US | disclosed |
| US-20240317653-A1 | USE OF A CATION SOURCE TO PREVENT DECOMPOSITION OF (THIO)PHOSPHORIC ACID TRIAMIDE UREASE INHIBITORS WHEN A PHOSPHORUS-CONTAINING FERTILIZER IS PRESENT | BASF SE (DE) | 2024-09-26 | — | — | US | disclosed |
| EP-4423040-A1 | UREASE INHIBITOR FORMULATION FOR USE IN UREA GRANULATION PROCESS | BASF SE (DE) | 2024-09-04 | — | — | EP | disclosed |
| US-12037300-B2 | Use of a cation source to prevent decomposition of (thio)phosphoric acid triamide urease inhibitors when a phosphorus-containing fertilizer is present | BASF SE (DE) | 2024-07-16 | — | — | US | disclosed |
| EP-3436416-B1 | USE OF A CATION SOURCE TO PREVENT DECOMPOSITION OF (THIO)PHOSPHORIC ACID TRIAMIDE UREASE INHIBITORS WHEN A PHOSPHORUS-CONTAINING FERTILIZER IS PRESENT | BASF SE (DE) | 2024-01-24 | — | — | EP | disclosed |
| WO-2023072798-A1 | UREASE INHIBITOR FORMULATION FOR USE IN UREA GRANULATION PROCESS | BASF SE (DE) | 2023-05-04 | — | — | WO | disclosed |
| EP-3356375-B1 | PROCESS FOR RECOVERING A MIXTURE COMPRISING A (THIO)PHOSPHORIC ACID DERIVATIVE | BASF SE (DE) | 2023-01-04 | — | — | EP | disclosed |
| EP-3356375-B1 | PROCESS FOR RECOVERING A MIXTURE COMPRISING A (THIO)PHOSPHORIC ACID DERIVATIVE | BASF SE (DE) | 2023-01-04 | — | — | EP | disclosed |
| US-10961264-B2 | Process for isolating a (thio)phosphoric acid derivative | BASF SE (DE) | 2021-03-30 | — | — | US | disclosed |
| US-10954256-B2 | Process for recovering a mixture comprising a (thio)phosphoric acid derivative | BASF SE (DE) | 2021-03-23 | — | — | US | disclosed |
| WO-2017093925-A1 | PROCESS FOR ISOLATING A (THIO)PHOSPHORIC ACID DERIVATIVE | BASF SE (DE) | 2017-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10961264-B2 | Process for isolating a (thio)phosphoric acid derivative | TST, SLC34A1, SLC34A2 | S1PR2 2577/4885S1PR4 2312/4885S1PR1 2858/4885 |
| US-10954256-B2 | Process for recovering a mixture comprising a (thio)phosphoric acid derivative | TST, MTAP, TPR | S1PR2 2204/4885S1PR4 1704/4885S1PR1 2676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.